Impact of chronic GLP-1 RA and SGLT-2I therapy on in-hospital outcome of diabetic patients with acute myocardial infarction

BACKGROUND: Glucagon-like peptide-1 receptor agonists (GLP-1 RA) and sodium glucose cotransporter-2 inhibitors (SGLT-2i) demonstrated cardiovascular and renal protection. Whether their benefits occur also during hospitalization for acute myocardial infarction (AMI) in patients with diabetes mellitus...

Descripción completa

Detalles Bibliográficos
Autores principales: Trombara, Filippo, Cosentino, Nicola, Bonomi, Alice, Ludergnani, Monica, Poggio, Paolo, Gionti, Luigia, Baviera, Marta, Colacioppo, Pierluca, Roncaglioni, Maria Carla, Leoni, Olivia, Bortolan, Francesco, Agostoni, Piergiuseppe, Genovese, Stefano, Marenzi, Giancarlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903538/
https://www.ncbi.nlm.nih.gov/pubmed/36747186
http://dx.doi.org/10.1186/s12933-023-01758-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903538/
https://www.ncbi.nlm.nih.gov/pubmed/36747186
http://dx.doi.org/10.1186/s12933-023-01758-y

Ejemplares similares